SARMS OTR-AC

OTR-AC, known as MK-2866 Ester, is a modified form of MK-2866 (Ostarine) that has been subjected to esterification, a chemical reaction that combines an organic acid with an alcohol. This modification enhances the compound's potency and extends its half-life, which refers to the duration needed for a substance to diminish to half of its original concentration. As a result of this esterification, the ester variant of Ostarine can maintain its bioactivity for a duration that is ten times longer. Consequently, this leads to several advantages, including reduced dosing frequency and more consistent blood concentration levels.

OTR-AC, an ester derivative of the selective androgen receptor modulator (SARM) ostarine, exhibits enhanced potency and prolonged effects. It binds to androgen receptors in the body, promoting the development of muscle tissue, which subsequently leads to an increase in both muscle mass and strength.

Studies suggest that OTR-AC along with other SARMs increases muscle mass and strength by stimulating the formation of muscle tissue, also evidence suggests that OTR-AC can help lower cholesterol levels especially low-density lipoprotein (bad cholesterol). Aside from helping gain muscle mass, OTR-AC has also been found to reduce overall body fat an stimulate bone formation and protect against bone disorders, also found, is that OTR-AC can help improve blood sugar levels in older people.

Possible side effects, seldom seen: headache, nausea, fatigue, back pain, elevation in liver enzymes such as alanine transaminase (ALT), reductions in high-density lipoprotein, low blood sugar, insulin resistance.